- Home
- AHG vs BVS Comparison
AHG vs BVS Comparison
Compare AHG & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHG
- BVS
- Stock Information
- Founded
- AHG 2013
- BVS 2011
- Country
- AHG China
- BVS United States
- Employees
- AHG N/A
- BVS N/A
- Industry
- AHG Business Services
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AHG Consumer Discretionary
- BVS Health Care
- Exchange
- AHG Nasdaq
- BVS Nasdaq
- Market Cap
- AHG 502.5M
- BVS 496.7M
- IPO Year
- AHG N/A
- BVS 2021
- Fundamental
- Price
- AHG $1.42
- BVS $6.77
- Analyst Decision
- AHG
- BVS Strong Buy
- Analyst Count
- AHG 0
- BVS 4
- Target Price
- AHG N/A
- BVS $15.00
- AVG Volume (30 Days)
- AHG 22.0K
- BVS 444.9K
- Earning Date
- AHG 05-16-2025
- BVS 05-06-2025
- Dividend Yield
- AHG N/A
- BVS N/A
- EPS Growth
- AHG N/A
- BVS N/A
- EPS
- AHG N/A
- BVS N/A
- Revenue
- AHG $8,454,946.00
- BVS $567,699,000.00
- Revenue This Year
- AHG N/A
- BVS N/A
- Revenue Next Year
- AHG N/A
- BVS $6.09
- P/E Ratio
- AHG N/A
- BVS N/A
- Revenue Growth
- AHG 281.19
- BVS 8.60
- 52 Week Low
- AHG $0.60
- BVS $4.51
- 52 Week High
- AHG $2.35
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- AHG 61.79
- BVS 36.21
- Support Level
- AHG $1.34
- BVS $6.02
- Resistance Level
- AHG $1.45
- BVS $7.07
- Average True Range (ATR)
- AHG 0.14
- BVS 0.38
- MACD
- AHG 0.02
- BVS -0.01
- Stochastic Oscillator
- AHG 77.66
- BVS 38.27
About AHG Akso Health Group ADS
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.